Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

477 Results

Document

H-CDM_FITInstructions

New

Mar 2026

Document

H-CDM_FITInstructions-FR

New

Mar 2026

Document

H-KOH_FITInstructions

New

Mar 2026

Document

H-KOH_FITInstructions-FR

New

Mar 2026

Document

H-FIT_PrimaryCareProviderFAQs

New

Mar 2026

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Regimen

TISL(MNT)

Cancer Type:

Head and Neck,

Nasopharynx

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

tislelizumab (Compassionate)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Updated

Apr 2026

High Risk Ontario Breast Screening Program Locations List

Guidelines and Advice

The Management of Depression in Patients with Cancer

Status: Current
ID: 19-4
Version: 2

Updated

Mar 2026

Pages